baber/WOPTO huggingface dataset:
Patent CY-1108485-T1 (CY)
Inventor: GLAESNER WOLFGANG
IPC: A61K38/00
Filed: 2008-11-06
Abstract: The present invention relates to glucagon-like-1 compounds fused to proteins that have the effect of extending the  in vivo  half-life of the peptides. These fusion proteins can be used to treat non-insulin dependent diabetes mellitus as well as a variety of other conditions.
Patent CY-1115510-T1 (CY)
Title: Πρωτοτυπα παραγωγα υπεροξειδιου, η διαδικασια παραγωγης τους και η χρηση τους σε ιατρικη και σε καλλυντικα για την θεραπευτικη ή προληπτικη αγωγη ακμης
Inventor: BOUIX-PETER CLAIRE
IPC: A61Q19/00
Filed: 2014-08-28
Abstract: Η παρούσα εφεύρεση σχετίζεται με την χρήση των ενώσεων του ακόλουθου γενικού τύπου (Ι). Σχετίζεται επίσης με την διαδικασία παραγωγής τους και με την θεραπευτική εφαρμογή τους.
Patent CY-1115751-T1 (CY)
Title: Φαρμακευτικος συνδυασμος 3-(3-διμεθυλαμινο-1-αιθυλ-2-μεθυλπροπυλ)-φαινολης και ενος αντιεπιληπτικου
Inventor: BLOMS-FUNKE PETRA
IPC: A61P25/04
Filed: 2014-09-16
Abstract: Η παρούσα εφεύρεση αφορά ένα συνδυασμό ο οποίος περιέχει ως συστατικά (α) μια τουλάχιστον ένωση 3-(3-διμεθυλαμινο-1-αιθυλ-2-μεθυλ-προπυλ)-φαινόλης και (β) ένα τουλάχιστον αντιεπιληπτικό, μια φαρμακευτική τυποποίηση και μια δοσολογική μορφή που περιέχουν τον εν λόγω συνδυασμό καθώς και μια μέθοδο θεραπείας του πόνου, π.χ. του νευροπαθητικού πόνου, όπου τα συστατικά (α) και (β) χορηγούνται ταυτόχρονα ή διαδοχικά σε ένα θηλαστικό, όπου το συστατικό (α) μπορεί να χορηγείται πριν ή μετά από το συστατικό (β) και όπου τα συστατικά (α) ή (β) χορηγούνται στο θηλαστικό είτε μέσω της ιδίας είτε μέσω μιας διαφορετικής οδού χορήγησης.
Patent CY-1118341-T1 (CY)
Title: Μεθοδος υδρογονωσης 1,2-ακορεστων καρβονυλικων ενωσεων
Inventor: HULTEBERG CHRISTIAN
IPC: C07C69/22
Filed: 2016-11-18
Abstract: Αποκαλύπτεται μια μέθοδος υδρογόνωσης μίας 1,2-ακόρεστης καρβονυλικής ένωσης, ώστε να ληφθεί η αντίστοιχη κεκορεσμένη καρβονυλική ένωση παρουσία καταλύτη παλλαδίου με ετερογενή κατανομή παλλαδίου.
Patent CY-1121047-T1 (CY)
Title: Ενωσεις αμιδιου για τη θεραπεια toy hiv
Inventor: BRIZGYS GEDIMINAS
IPC: A61K31/496
Filed: 2018-09-12
Abstract: Αποκαλύπτονται ενώσεις του τύπου (I) ή άλατα αυτών. Επίσης αποκαλυπτόμενες είναι φαρμακευτικές συνθέσεις που περιλαμβάνουν ένωση του τύπου I, μέθοδοι για παρασκευή ενώσεων του τύπου I, ενδιάμεσα χρήσιμα για παρασκευή ενώσεων του τύπου I και θεραπευτικές μέθοδοι για θεραπεία ιικής μόλυνσης Ρετροϊών που συμπεριλαμβάνουν μόλυνση που προκαλείται με τον HIV ιό.
Patent CY-1121110-T1 (CY)
Title: Αντινοηματικα-ολιγονουκλεοτιδια ως παρεμποδιστες σηματοδοτησης tgf-r
Inventor: HOSSBACH MARKUS
IPC: A61K31/7125
Filed: 2018-12-28
Abstract: Η παρούσα εφεύρεση αφορά σε αντινοηματικά-ολιγονουκλεοτίδια που έχουν μήκος τουλάχιστον 10 νουκλεοτιδίων, όπου τουλάχιστον δύο από τα νουκλεοτίδια είναι LNAs, χρήση αυτών ως παρεμποδιστών σηματοδότησης TGF-R, φαρμακευτικές συνθέσεις που περιέχουν τέτοια αντινοηματικά ολιγονουκλεοτίδια και τη χρήση για προφύλαξη και θεραπεία νευρολογικών, νευροεκφυλιστικών, ινωτικών και υπερπολλαπλασιαστικών ασθενειών.
Patent GR-900300197-T1 (GR)
Title: Method for adaptively sharpening electronic images
Inventor: SONG WOO-JIN
IPC: H04N5/21
Filed: 1991-10-10
Abstract: Method and apparatus for sharpening edges and details of a digital image without amplifying noise in the digital image provide an output image which is the sum of the input image and its adaptively-amplified high frequency components, which adaptively amplified high frequency components are obtained by subtracting a low-pass filtered image from the input image. An adaptive amplification factor for the high frequency components is determined as a function of a variance of the pixel values surrounding a pixel and the noise power of the imaging system.
Patent GR-940300036-T1 (GR)
Title: Support for a heart valve prosthesis
Inventor: RELIGA ZBIGNIEW
IPC: A61F2/24
Filed: 1994-06-30
Abstract: PCT No. PCT/EP92/01017 Sec. 371 Date Jan. 14, 1994 Sec. 102(e) Date Jan. 14, 1994 PCT Filed May 8, 1992 PCT Pub. No. WO92/19184 PCT Pub. Date Nov. 12, 1992.A heart valve prothesis is formed from a support having a textile covering. The support is formed from a single piece of flat, preferably thermoplastic material, arranged to form an annular structure, which preferably is either a hollow cylinder or a hollow cone.
Patent HR-P20110045-T1 (HR)
Inventor: PORTMANN ROBERT
IPC: C07D223/12
Filed: 2011-01-21
Abstract: Postupak za pripremanje spojeva formule Iili njihovog solvata ili hidrata, gdjeR je fenil koji je nesupstituiran ili je supstituiran sa 1, 2 ili 3 supstituenta odabranih iz skupine koja sadrži halogen, C1-C7-alkil, trifluorometil, hidroksi i C1-C7-alkoksi; R1 je vodik ili C1-C7-alkil; R2 je vodik, C1-C7-alkil ili fenil koji je nesupstituiran ili je supstituiran sa 1, 2 ili 3 supstituenta odabranih iz skupine koja sadrži halogen, C1-C7-alkil, trifluorometil, hidroksi i C1-C7-alkoksi; R3 je fenil koji je nesupstituiran ili je supstituiran sa 1, 2 ili 3 supstituenta odabranih iz skupine koja sadrži halogen, C1-C7-alkil, trifluorometil, hidroksi i C1-C7-alkoksi, ili R3 je naftil, 1H-indol-3-il ili 1-C1-C7-alkil-indol-3-il; iR5 je C3-C8-cikloalkil, D-azacikloheptan-2-on-3-il ili L-azacikloheptan-2-on-3-il, naznačen time, da se postupak sastoji od sljedećih koraka: (a)	reagiranje spoja formule IIgdje su R1 , R2 , R3 i R5 kako su određeni prethodno u ovom zahtjevu i T je BOC zaštitna skupina, pri čemu BOC je t-butoksikarbonil, s bazom za formiranje spoja formule IIIgdje su R1 , R2 , R3 i R5 kako su određeni prethodno u ovom zahtjevu, i (b)	reagiranje spoja formule III gdje su R1 , R2 , R3 i R5 kako su određeni prethodno u ovom zahtjevu, sa spojem formule IVgdje R je fenil koji je nesupstituiran ili je supstituiran sa 1, 2 ili 3 supstituenta odabranih iz skupine koja sadrži halogen, C1-C7-alkil, trifluorometil, hidroksi i C1-C7-alkoksi, a X je halo, u prisutnosti baze za formiranje spoja formule I, te (c)	opcijski, formiranje njegovog željenog solvata ili hidrata. Patent sadrži još 4 patentna zahtjeva.
Patent HR-P20110085-T1 (HR)
Inventor: WIHSMANN MARC
IPC: A61K47/32
Filed: 2011-02-03
Abstract: Oftalmički pripravak naznačen time da sadrži od 0.05 do 0.3% w/w brivudina kao aktivni sastojak i sredstvo za tvorbu film-ovojnice odabrano iz sljedeće skupine: polivinil pirolidon (PVP), polivinil alkohol (PVA) i poliakrilat (PA). Patent sadrži još 13 patentnih zahtjeva.
Patent HR-P20110335-T1 (HR)
Inventor: DOW ROBERT LEE
IPC: C07D498/04
Filed: 2011-05-06
Abstract: Spoj formuleili njegov tautomer, ili farmaceutski prihvatljiva sol navedenog spoja ili tautomera, naznačen time što: (a)	R1 je H -(C1-C4)alkil, -(C1-C4)perfluoralkil, -(C1-C4)perfluoralkoksi ili -(C1-C4)alkoksi; (b)	R2 i R3, uzeti odvojeno, su neovisno H, -(C1-C4)alkil ili -(C1-C4)perfluoralkil; ili R2 i R3, uzeti zajedno s ugljikom na kojeg su vezani, su -(C3-C6)cikloalkil; (c)	R4 je H ili -(C1-C4)alkil; (d)	svaki od R5a, R5b, R5c i R5d je neovisno H, F, Cl, Br, -(C1-C4)alkil, -OH ili -O-(C1-C4)alkil; (e)	Q je -O- ili veza; (f)	A je -(C3-C6)cikloalkilenska skupina, -(C3-C6)cikloalkenilenska skupina ili fenilen; (g)	Z je -C(R6a)(R6b)- ili veza, gdje svaki od R6a i R6b je neovisno -H ili -(C1-C4)alkil, ili R6a i R6b, uzeti zajedno s ugljikom na kojeg su vezani, su -(C3-C6)cikloalkil; (h)	R7 je C(O)R8, cijano, hidroksil, -(C1-C4)alkoksi, -(C1-C4)perfluoralkoksi ili mimetik karboksilne kiseline; (i)	R8 je -OR9 ili NHR10; (j)	R9 je -H, -(C1-C4)alkil ili -(C1-C4)perfluoralkil; i (k)	R10 je -H, -(C1-C4)alkil, tetrazolil ili S(O)2CF3;gdje mimetik karboksilne kiseline se bira između -SO3H, -CH2S(O)2R7, -C(O)NHS(O)2R7, -C(O)NHOH, -C(O)NHCN, -C(O)NHR7, -CH(CF3)OH, -C(CF3)2OH, -P(O)(OH)2, 1,2,5-tiadiazol-3-ol-4-ila, 1H-tetrazol-5-ila, 1H-1,2,4-triazol-5-ila, 1H-pirazol-5-ol-3-ila, izoksazol-5-ol-3-ila, izoksazol-3-ol-5-ila, tiazolidin-2,4-dion-5-ila, imidazolidin-2,4-dion-5-ila, 1H-pirol-2,5-dion-3-ila, 1H-imidazol-2-ol-5-ila, dihidropirimidin-2,4(1H,3H)-dion-6-ila, imidazolidin-2,4-dion-1-ila, 1H-imidazol-5-ol-2-ila, 1H-pirazol-3-ol-1-ila, 1H-pirazol-3-ol-4-ila, 1,3,4-tiadiazol-2-ol-5-ila, 1,3,4-oksadiazol-2-ol-5-ila, 1,2,4-oksadiazol-3-ol-5-ila, 1,2,4-tiadiazol-3-ol-5-ila, oksazol-2-ol-4-ila, tiazol-2-o-4-ila, tiazol-4-ol-2-ila, 1,2,4-oksadiazol-5-ol-3-ila, 1,2,4-tiadiazol-5-ol-3-ila, 1,1-di-okso-1,2,5-tiadiazolidin-3-on-2-ila, 1,1-di-okso-1,2,5-tiadiazolidin-3-on-5-ila, izotiazol-3-ol-5-ila, 2H-1,2,3-triazol-4-ol-2-ila, 1H-1,2,3-triazol-4-ol-1-ila, 1H-imidazol-2,4-diol-5-ila, 1-okso-2,3-dihidro-1,2,4-tiadiazol-5-ol-3-ila, tiazol-2,4-diol-5-ila, oksazol-2,4-diol-5-ila, 3,4-dihidroksifuran-2(5H)-on-5-ila, te 5-hidroksi-1,2,4-tiadiazol-3(2H)-on-2-ila, gdje R7 je -H, -(C1-C4)alkil ili -(C3-C6)cikloalkil. Patent sadrži još 21 patentni zahtjev.
Patent HR-P20110705-T1 (HR)
Title: Device for feeding coins into the aperture in a coin operated apparatus
Inventor: GAUSELMANN PAUL
IPC: G07F1/02
Filed: 2011-10-04
Abstract: The device has an auxiliary force-operated actuating drive (14) assigned to a coin receiver (10), where coins present in the coin receiver are transported to a coin receiving opening (7) by the actuating drive. The coin receiver has a coin conveying bar (13), which supplies the coins of the coin receiving opening in an overlaid stroke and horizontal translatory motion by the actuating drive. The conveying bar is raised by eccentric cams (21, 23) and horizontally moved by an eccentric cam (22), and has rectangle-shaped recesses and/or break-throughs (24-26).
Patent HR-P20130345-T1 (HR)
Title: New therapeutic approaches for treating cmt and related disorders
Inventor: COHEN DANIEL
IPC: A61K45/06
Filed: 2013-04-17
Abstract: The present invention relates to compositions and methods for the treatment of the Charcot-Marie-Tooth disease and related disorders. More particularly, the invention relates to combined therapies for treating said disease by affecting PMP22 expression in a subject.
Patent SI-1270570-T1 (SI)
Title: Amide compounds and use thereof
Inventor: TAKANASHI SHINICHI
IPC: A61K31/00
Filed: 2001-03-16
Abstract: The present invention relates to an amide compound of the formula   <CHEM> wherein R<1> is a hydrogen and the like, R<2> is a hydrogen and the like, X is SO2 and the like, Y is the formula (III) and the like and a is 2, an isomer thereof or pharmaceutically acceptable salts thereof. The compound of the present invention shows a remarkable and selective Rho kinase inhibitory action, is free of problematic toxicity, shows fine oral absorption and drug kinetics (absorption, distribution, metabolism, excretion and the like of the drug), and shows superior properties (e.g., stability etc.) as a compound. Accordingly, it can be used as a therapeutic drug for various diseases in which Rho kinase is involved.
Patent SI-1384514-T1 (SI)
Title: Rotary sprayer and bearing for this sprayer
Inventor: NOLTE HANS-JURGEN DR
IPC: B05B3/00
Filed: 2003-07-18
Abstract: The rotating atomizer has a rotating shaft for the cup plate (4) to generate a spray stream at the surface to be coated, and at least one deflection outflow (8,9) for deflection air forming the spray stream. An air supply line (18) within the housing (7), to deliver air to the deflection outflows, passes at least partially axially through the bearing unit (19) of the drive turbine (5).  The bearing unit has at least one deflection air outlet at its mantle surface, linked by a drilling (23) to the deflection air outlet at the end side towards the cup plate.
Patent SI-1694828-T1 (SI)
Title: Serum-free vero cell banking process
Inventor: ALLIKMETS ENE
IPC: C12N5/00
Filed: 2004-12-10
Abstract: A serum-free Vero cell banking process provides a standardized and consistent way to generate reliable and stable cell banks for viral vaccine production. The substitution of animal-derived substances with plant-derived substances in the growth and freezing media increases the viability of the cells upon thawing and reduces their recovery time, thereby allowing a more precise schedule for manufacturing and more consistent processes.
Patent SI-1996163-T1 (SI)
Title: Process for producing a solid dispersion of an active ingredient
Inventor: KESSLER THOMAS
IPC: B29C48/41
Filed: 2007-03-12
Abstract: The present invention relates to a solid dispersion comprising a biologically active ingredient and a matrix-forming agent, wherein the biologically active ingredient comprises ritonavir and the solid dispersion has been obtained by a process which comprises feeding the active ingredient and a matrix-forming agent to an extruder and forming a uniform extrudate, wherein the extruder comprises at least two rotating shafts (2), each of the shafts (2) carrying a plurality of processing elements disposed axially one behind the other, the processing elements defining (i) a feeding and conveying section (A), (ii) at least one mixing section (B), and (iii) a discharging section (E), wherein the processing element(s) defining the mixing section (B) comprise(s) a mixing element (11, 12, 13) that is derived from a screw type element.
Patent SI-3056485-T1 (SI)
Title: Androgen receptor modulating compounds
Inventor: WOHLFAHRT GERD
IPC: C07D231/00
Filed: 2010-10-27
Abstract: Compounds of formula (I) wherein R 1  to R 16 , A. B and E are as defined in the claims and pharmaceutically acceptable salts and esters thereof, are disclosed. The compounds of formula ( I ) possess utility as tissue-selective androgen receptor modulators (SARM) and are particularly useful as medicaments in the treatment of prostate cancer and other AR dependent conditions and diseases where AR antagonism is desired.
Patent DE-3685786-T2 (DE)
Inventor: BOLIS GOFFREDO ANTONIO
IPC: C07K1/12
Filed: 1986-09-05
Granted: 1993-01-21
Abstract: A method for the removal of the formyl group from an ester of an N-formyl peptide or N-formyl aminoacid, in which the ester is reacted with urea in the presence of a polar solvent and a strong acid.
Patent DE-3780196-T2 (DE)
Inventor: PALMER JOHN MALCOLM
IPC: G02B23/22
Filed: 1987-03-13
Granted: 1992-12-24
Abstract: An optical substantially afocal beam expander has a negative lens element (1) spaced from a positive lens element (2). The lens elements are of different materials with respective coefficients of refractive index change with respect to temperature such that the effect of a temperature change on one element is at least partially compensated by the effect of the temperature change on the other element. The beam expander is therefore substantially athermalised with respect to afocality.
Patent DE-3780647-T2 (DE)
Inventor: JONES ROBIN
IPC: G01J1/42
Filed: 1987-11-23
Granted: 1993-03-11
Abstract: PCT No. PCT/GB87/00837 Sec. 371 Date May 16, 1989 Sec. 102(e) Date May 16, 1989 PCT Filed Nov. 23, 1987 PCT Pub. No. WO88/04034 PCT Pub. Date Jun. 2, 1988.An avalanche photodiode quenching circuit comprises a low value photodiode series resistor and a comparator amplifier. The comparator compares the photodiode potential with a reference voltage and changes state rapidly after initiation of a photodiode avalanche. The photodiode is actively quenched by taking its potential below breakdown. This achieved by a fast-switching transistor activated by avalanche detection at the comparator. A further fast-switching transistor is arranged to reset the comparator input after a preset delay following avalanche detection. The photodiode recharges passively through the series resistor at a rapid rate since this resistor has a low value. The quench and reset transistors are deactivated by comparator reset, the latter after the preset delay once more, and are isolated from the photodiode during recharge by diodes. The invention avoids the use of active photodiode reset pulses, and has constant output pulse width and well-defined dead-time.
Patent DE-3786055-T2 (DE)
Inventor: PARRENT GEORGE B
IPC: G01N1/28
Filed: 1987-08-27
Granted: 1993-10-21
Abstract: In a chemical analysis apparatus a controlled sample liquid is passed through a non-wetting porous membrane (23) in a diluter assembly (12) from a reservoir of sample liquid to a flowing stream of diluent which is constantly flowing. The sample liquid penetrates the membrane (23) under a positive pressure differential from the sample side of the membrane (23). Control is provided by varying the resistance to flow of the sample liquid, and the pressure on the sample liquid, as it flows through the diluter assembly (12). Passage of the sample liquid through the membrane (23) requires a minimum liquid entry pressure differential across the membrane (23) to cause enough penetration to give a detectable presence of the sample liquid in the diluent stream for analysis by an analytical detector (19).
Patent DE-3850542-T2 (DE)
Inventor: ZARLING JOYCE M
IPC: C07K16/00
Filed: 1988-09-22
Granted: 1994-11-24
Abstract: The present invention relates to novel antibody heteroconjugates and their use in methods for killing HIV-infected cells. The heteroconjugates are comprised of an antibody specific for an HIV antigen that is expressed on HIV-infected cells cross-linked to an antibody specific for an effector cell of the peripheral blood capable of killing an HIV-infected target cell. The antibody heteroconjugates of the invention physically bridge the effector cell to the target cell and may activate the lytic mechanism of the effector cell in the killing of the HIV-infected target cell. The methods, heteroconjugates, pharmaceutical compositions and combinations described herein provide a novel approach to the treatment of HIV-infected individuals by amplifying endogenous HIV-specific effector mechanisms and may also be of prophylactic value in individuals newly infected or accidentally exposed to the HIV virus.
Patent DE-3878313-T2 (DE)
Inventor: ANGELICO MARIO
IPC: A61K31/575
Filed: 1988-05-26
Granted: 1993-05-27
Abstract: Pharmaceutical compositions for the prophylaxis and therapy of biliary tract calculosis and of biliary dyspepsia, containing as the active principle taurohyodeoxycholic acid, are herein described.
Patent DE-3883825-T2 (DE)
Inventor: GREGORY RICHARD
IPC: B01D53/34
Filed: 1988-04-11
Granted: 1994-01-13
Abstract: Method which includes passing a gas stream containing carbon dioxide, hydrogen sulfide, sulfur dioxide, mercaptans and other acid gases through an aqueous alkanolamine solution to remove the carbon dioxide, hydrogen sulfide, sulfur dioxide, mercaptans, etc., from the gaseous stream. Heat-stable alkanolamine salts form in the aqueous alkanolamine solution due to the acid contaminants (other than hydrogen sulfide or carbon dioxide) removed from the gas stream. A base is added to the aqueous alkanolamine solution to convert all or part of the heat-stable alkanolamine salts into alkanolamine and simple salts. The base-treated aqueous alkanolamine solution is electrodialyzed in an electrodialysis cell containing ion exchange membranes. The purified aqueous alkanolamine solution can be used again to remove carbon dioxide, etc., from the gas stream.
Patent DE-60001873-T2 (DE)
Inventor: PETRELLA ROBERT GABRIEL
IPC: C08J9/14
Filed: 2000-06-16
Granted: 2004-02-05
Abstract: A method for preparing a polyurethane flexible foam by reacting an organic polyisocyanate with a polyol in the presence of urethane catalyst, water as a blowing agent, optionally a silicone surfactant, and a cell opener characterized in that the cell opener comprises the reaction product of a C1-C20 hydrocarbyl group-containing organic acid anhydride and 2,2,4-trimethyl-1,3-pentanediol monoisobutyrate, optionally reacted in the presence of a tertiary amine urethane catalyst.
Patent DE-60008430-T2 (DE)
Inventor: SALL JON
IPC: C07D333/16
Filed: 2000-11-03
Granted: 2004-12-23
Abstract: This application relates to novel compounds of formula (I) (and their pharmaceutically acceptable salts), as defined herein, processes and intermediates for their preparation, pharmaceutical formulations comprising the novel compounds of formula (I), and the use of defined compounds of formula (I) as thrombin inhibitors.
Patent DE-60009908-T2 (DE)
Inventor: COLLIER DIGBY
IPC: H03L7/18
Filed: 2000-07-18
Granted: 2005-04-07
Abstract: A variable frequency oscillator comprising: an oscillatory circuit for generating a periodic output dependent on the capacitance between a first node and a second node of the circuit, and having a capacitative element connected between the first node and the second node; the capacitative element comprising: a variable capacitance unit, the capacitance of which is variable for varying the frequency of the output and a plurality of finite capacitances each being selectively connectable in parallel with the variable capacitance unit between the first node and the second node to trim the frequency of the output.
Patent DE-60016915-T2 (DE)
Inventor: DETABLE PASCAL
IPC: F16L21/06
Filed: 2000-06-02
Granted: 2005-12-15
Abstract: A device for coupling together in leaktight manner two smooth tubes disposed end-to-end, the device comprising a sleeve which diameter can be reduced by a tightening action, and a sealing ring (24) suitable for being disposed inside the sleeve so as to surround the ends of the two tubes. The ring is constituted by a looped flat strip (26) having two longitudinal ends (26a, 26b) suitable for coming into contact with each other when the sleeve is tightened around the tubes (20, 22). The first longitudinal end of the ring is provided with a notch (28), while the second longitudinal end of the ring is in the form of a tongue (30) suitable for being inserted into the notch. Both the width of the tongue and also the width of the notch taper in the direction going along the strip from the first longitudinal end to the second longitudinal end. When the tongue is in a partial insertion position in which it is inserted partially in the notch, the two sides (30a, 30b) of the tongue are suitable for coming into contact with the two sides (28a, 28b) of the notch while the free end (30a) of the tongue remains at a distance from the end wall (28c) of the notch, and, starting from the partial insertion position, the tongue is suitable for penetrating further into the notch under the effect of the tightening.
Patent DE-60026269-T2 (DE)
Inventor: DAUGA CHRISTOPHE
IPC: A61K8/34
Filed: 2000-10-23
Granted: 2006-11-09
Abstract: Topical composition contains a copolymer with an optical brightener(s) covalently fixed to a copolymer chain.